Biotech · Private company
Foundation Medicine
Track this companyFree. Adds Foundation Medicine to your Dealase workspace and tells you when its record changes.
Clinical trials218 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials21
- Prospective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for Detection of Estrogen Receptor 1 (ESR1) Mutations in (Human Epidermal Growth Factor Receptor) HR+/HER2- Metastatic Breast Cancer (MBC)NA · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07910565 · fetched Nov 12, 2026
- Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCPHASE2 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06745882 · fetched Nov 12, 2026
- Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment DiscontinuationNA · ACTIVE_NOT_RECRUITING · started Jan 10, 2024ClinicalTrials.gov NCT06146920 · fetched Nov 12, 2026
- A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPHASE1_PHASE2 · RECRUITING · started Oct 20, 2021ClinicalTrials.gov NCT04486352 · fetched Nov 12, 2026
- Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast CancerPHASE2 · TERMINATED · started Aug 24, 2021ClinicalTrials.gov NCT04849364 · fetched Nov 12, 2026
- TCF-001 TRACK (Target Rare Cancer Knowledge) StudyNA · RECRUITING · started Oct 1, 2020ClinicalTrials.gov NCT04504604 · fetched Nov 12, 2026
- A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)PHASE2 · TERMINATED · started Aug 23, 2019ClinicalTrials.gov NCT03824704 · fetched Nov 12, 2026
- Rucaparib in Patients With Locally Advanced or Metastatic Urothelial CarcinomaPHASE2 · TERMINATED · started Jun 1, 2018ClinicalTrials.gov NCT03397394 · fetched Nov 12, 2026
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyPHASE3 · ACTIVE_NOT_RECRUITING · started May 14, 2018ClinicalTrials.gov NCT03522246 · fetched Nov 12, 2026
- Personalized Molecular Profiling in Cancer Treatment at Johns HopkinsNA · ACTIVE_NOT_RECRUITING · started Jan 26, 2018ClinicalTrials.gov NCT02965755 · fetched Nov 12, 2026
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyPHASE3 · COMPLETED · started Jun 13, 2017ClinicalTrials.gov NCT02975934 · fetched Nov 12, 2026
- ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsPHASE3 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT02855944 · fetched Nov 12, 2026
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyPHASE2 · COMPLETED · started Feb 15, 2017ClinicalTrials.gov NCT02952534 · fetched Nov 12, 2026
- Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)PHASE3 · COMPLETED · started Feb 6, 2017ClinicalTrials.gov NCT02987543 · fetched Nov 12, 2026
- Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic AlterationsPHASE2 · COMPLETED · started Sep 28, 2016ClinicalTrials.gov NCT02795156 · fetched Nov 12, 2026
- Next Generation Personalized Neuroblastoma TherapyPHASE1 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02780128 · fetched Nov 12, 2026
- Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis CancersCOMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02534675 · fetched Nov 12, 2026
- Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)PHASE3 · COMPLETED · started Apr 7, 2014ClinicalTrials.gov NCT01968213 · fetched Nov 12, 2026
- A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)PHASE2 · COMPLETED · started Oct 30, 2013ClinicalTrials.gov NCT01891344 · fetched Nov 12, 2026
- A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)PHASE1_PHASE2 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01482715 · fetched Nov 12, 2026
- Molecular Studies and Clinical Correlations in Human Prostatic DiseaseACTIVE_NOT_RECRUITING · started Apr 1, 1990ClinicalTrials.gov NCT00578240 · fetched Nov 12, 2026